Women with an HbA1c of 41-49 mmol/mol (5.9-6.6%): A higher risk subgroup that may benefit from early pregnancy intervention

Diabetic Medicine

Volumn 33, Issue 1, 2016, Pages 25-31

  Rowan, J A ^a   Budden, A ^a   Ivanova, V ^a   Hughes, R C ^b   Sadler, L C ^a,c  

^a National Women's Health   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CAUCASIAN; COMPARATIVE STUDY; DIABETES, GESTATIONAL; EARLY DIAGNOSIS; ETHNOLOGY; FEMALE; HIGH RISK PREGNANCY; HUMAN; INFANT, NEWBORN, DISEASES; MALE; NEW ZEALAND; NEWBORN; NEWBORN INTENSIVE CARE; OCEANIC ANCESTRY GROUP; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; PRENATAL DIAGNOSIS; RISK FACTOR; SECOND TRIMESTER PREGNANCY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES, GESTATIONAL; EARLY DIAGNOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE, NEONATAL; MALE; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 84955739431     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12812     Document Type: Article

References (15)

1. Cundy T, Gamble G, Townend K, Henley P, MacPherson P, Roberts A. Perinatal mortality in type 2 diabetes mellitus. Diabet Med 2000; 17: 33-39.
2. Most OL, Kim JH, Arslan AA, Klauser C. Maternal and neonatal outcomes in early glucose tolerance testing in an obstetric population in New York city. J Perinat Med 2009; 37: 114-117.
3. 1c units for the diagnosis of Type 2 diabetes. NZ Med J 2012; 125: 70-80.
4. 1c ≥ 5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care 2014; 37: 2953-2959.
5. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust NZ J Obstet Gynaecol 2000; 40: 139-155.
6. 1c) in pregnancy. Clin Chem Lab Med 2012; 50: 905-909.
7. 1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004; 27: 1200-1201.
8. Barrett HL, Dekker Nitert M, McIntyre HD, Hague WM, Callaway LK, Rowan J. Predictors of preeclampsia in women in the metformin in gestational diabetes (MiG) study. Diabetes Metab 2014; 5: 395.
9. Holmes VA, Young IS, Patterson CC, Pearson DW, Walker JD, Maresh MJ et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 2011; 34: 1683-1688.
10. Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477-2486.
11. Landon MB. Is there a benefit to the treatment of mild gestational diabetes mellitus? Am J Obstet Gynecol 2010; 202: 649-653.
12. Cundy T, Gamble G, Neale L, Elder R, McPherson P, Henley P et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care 2007; 30: 2603-2607.
13. Hedderson M, Ferrara A, Sacks D. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycaemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 2003; 102: 850-856.
14. Rowan JA, Gao W, Hague WM, McIntyre HD. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 2010; 33: 9-16.
15. 1c in pregnancy: an additional group of women with gestational diabetes. Aust NZ J Obstet Gynaecol 2014; 54: 177-180.